XML 27 R18.htm IDEA: XBRL DOCUMENT v3.25.3
CONCENTRATIONS
 9 Months Ended
Sep. 30, 2025
Risks and Uncertainties [Abstract]  
CONCENTRATIONS

NOTE 11– CONCENTRATIONS

 

Milestone Scientific has informal arrangements with third-party U.S. manufacturers of the STA devices, and epidural instruments pursuant to which they manufacture these products under specific purchase orders which contains advance payments for long lead items for production. Advances on contracts have been classified as current at September 30, 2025 and December 31, 2024. The termination of the manufacturing relationship with any of these manufacturers could have a material adverse effect on Milestone Scientific’s ability to produce and sell its products. Although alternate sources of supply exist, and new manufacturing relationships could be established, Milestone Scientific would need to recover its existing tools or have new tools produced. Establishing new manufacturing relationships could involve significant expense and delay. Any curtailment or interruption of the supply, because of termination of such a relationship, would have a material adverse effect on Milestone Scientific’s financial condition, business, and results of operations.

 

 

On January 3, 2023, the Company launched an E-Commerce platform selling and shipping STA Single Tooth Anesthesia System® (STA) and handpieces directly to dental offices and dental groups within the U.S. For the three months ended September 30, 2025, and September 30, 2024, E-Commerce accounted for 43% and 45% of net product sales, respectively. For the three months ended September 30, 2025, no international distributor accounted for 10% of net product sales. For the three months ended September 30, 2024, one international distributor accounted for 11% of net product sales. For the nine months ended September 30, 2025, and September 30, 2024, E-Commerce accounted for 48% and 53% of net product sales, respectively. For the nine months ended September 30, 2025, no international distributor accounted for 10% of net product sales. For the nine months ended September 30, 2024, E-Commerce accounted for 53% of net product sales and one international distributor accounted for 10% of net product sales

 

The Company had three distributors that accounted for 28%, 14%, 14% of accounts receivable, respectively, for nine months ended September 30, 2025. The Company had three distributors that accounted for 22%, 13% and 11% of accounts receivable, respectively as of December 31, 2024. 

 

As of September 30, 2025, the Company had three suppliers that accounted for 33%, 24% and 19%, respectively, of accounts payable and accounts payable, related party. The Company had two suppliers that accounted for 31% and 30%, respectively of accounts payable and accounts payable, related party as of December 31, 2024.